CTTH - CTT Pharma appoints Ryan Khouri as CEO
CTT Pharma (OTCPK:CTTH) has appointed Ryan Khouri as its new CEO. Mr Khouri's engagement with the Company started as an investor who viewed CTT's unique drug delivery system as the future industry standard. Additionally, Dr Modi has stepped down as President and as a board member to assist sales teams with technical know-how and formulation. The company will be a sales-centered company that will focus on commercializing IP and removing barriers to sales. It will keep its shareholders updated as it executes on new partnerships and further evolves its patent portfolio.
For further details see:
CTT Pharma appoints Ryan Khouri as CEO